What is the current Price Target for the Neoleukin Therapeutics Inc stock?

The average Neoleukin Therapeutics Inc target price is $61.20. This is 204.93% higher than the current stock price. The highest price target is 266.22%, the lowest is 131.49%. 6 Analysts have issued a price target Neoleukin Therapeutics Inc 2026 .

How high will the Neoleukin Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Neoleukin Therapeutics Inc stock will rise. The performance of stocks, including the Neoleukin Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Neoleukin Therapeutics Inc stock today?

The performance of Neoleukin Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Neoleukin Therapeutics Inc stock fall?

The decline in Neoleukin Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Neoleukin Therapeutics Inc Forecast, price target & analysts

$20.07

0.05% yesterday

Nasdaq, Dec 24, 07:00 pm CET

ISIN

US64049K1043

Symbol

NGNE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Neoleukin Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Neoleukin Therapeutics Inc Classifications & Recommendation:

Buy

92%

Hold

Neoleukin Therapeutics Inc Price Target

Target Price	$61.20
Price	$20.07
Potential	204.93% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Neoleukin Therapeutics Inc 2026 . The average Neoleukin Therapeutics Inc target price is $61.20. This is 204.93% register free of charge higher than the current stock price. The highest price target is $73.50 266.22% register free of charge , the lowest is $46.46 131.49% register free of charge .
	A rating was issued by 12 analysts: 11 Analysts recommend Neoleukin Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Neoleukin Therapeutics Inc stock has an average upside potential 2026 of 204.93% register free of charge . Most analysts recommend the Neoleukin Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-4.28	-4.28
	51.24%	0.00%
P/E		negative

8 Analysts have issued a Neoleukin Therapeutics Inc forecast for earnings per share. The average Neoleukin Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.28	51.24%
2025	$-4.28 0.00% Unlock
2026	$-5.31 24.07% Unlock
2027	$-6.12 15.25% Unlock

Current	-10.51	94.47%
2025	-4.69 55.37% Unlock
2026	-3.78 19.40% Unlock
2027	-3.28 13.23% Unlock

Neoleukin Therapeutics Inc...

Current Neoleukin Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 13 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 31 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 09 2025
Craig-Hallum	Locked ➜ Locked	Locked	Jun 17 2025
BMO Capital	Locked ➜ Locked	Locked	Jun 12 2025
BMO Capital	Locked ➜ Locked	Locked	May 20 2025
Baird	Locked ➜ Locked	Locked	May 16 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 13 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 31 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 09 2025
Locked Craig-Hallum: Locked ➜ Locked	Jun 17 2025
Locked BMO Capital: Locked ➜ Locked	Jun 12 2025
Locked BMO Capital: Locked ➜ Locked	May 20 2025
Locked Baird: Locked ➜ Locked	May 16 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 70.19%

Netflix 51.41%

BioNTech SE - ADR 50.27%

Deutsche Telekom 41.05%

Alibaba Group Holding Ltd 40.63%

Uber Technologies 38.26%

Adyen 36.45%

PayPal 35.91%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now